These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6058030)

  • 1. Intermittent chemotherapy with isoniazid and streptomycin in Algiers.
    Chaulet P; Larbaoui D; Grosset J; Abderrahim K
    Tubercle; 1967 Jun; 48(2):128-36. PubMed ID: 6058030
    [No Abstract]   [Full Text] [Related]  

  • 2. [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. Relationship between the incidence of drug resistance and the course of original treatment].
    Yamamoto M; Nakamura H
    Kekkaku; 1971 Jun; 46(6):191-5. PubMed ID: 4997826
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preliminary report on out-patient intermittent drug therapy in cases of active sputum-positive pulmonary tuberculosis].
    Zielniewicz B; Klimczyk M; Chodera B
    Gruzlica; 1971 Jul; 39(7):668-70. PubMed ID: 5117146
    [No Abstract]   [Full Text] [Related]  

  • 4. [Proceedings: Current status and perspectives of tuberculosis chemotherapy in Algeria].
    Larbaoui D; Chaulet P
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):139-46. PubMed ID: 4491711
    [No Abstract]   [Full Text] [Related]  

  • 5. Rifampin in association with isoniazid, streptomycin, and ethambutol, respectively, in the initial treatment of pulmonary tuberculosis.
    Nitti V; Catena E; Delli Veneri F; De Michele G; Marra A
    Am Rev Respir Dis; 1971 Mar; 103(3):329-37. PubMed ID: 5005040
    [No Abstract]   [Full Text] [Related]  

  • 6. Rifampin-isoniazid compared with streptomycin-isoniazid in the original treatment of infectious pulmonary tuberculosis. Results of a controlled study.
    Favez G; Chioléro R; Willa C
    Chest; 1972 Jun; 61(6):583-6. PubMed ID: 4624280
    [No Abstract]   [Full Text] [Related]  

  • 7. Relapse in tuberculosis. A report from the Research Committee of the South-East Metropolitan Regional Thoracic Society.
    Br J Dis Chest; 1973 Jan; 67(1):33-42. PubMed ID: 4688044
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparative study on an intermittent mode of pulmonary tuberculosis therapy using streptomycin and isoniazid].
    Burzibu JM; Durante C; Ceicu A; el Fassi el Fahri M; Bahsoun H
    Maroc Med; 1974 May; 54(579):307-13. PubMed ID: 4444314
    [No Abstract]   [Full Text] [Related]  

  • 9. Intermittent ambulatory treatment of tuberculosis once a week, preceded by a 30-day intensive hospital treatment.
    Calvo AS; Serrano T; Rivas HD; Iturbe P
    Bull Int Union Tuberc; 1968 Dec; 41():331-4. PubMed ID: 5710258
    [No Abstract]   [Full Text] [Related]  

  • 10. Co-operative controlled trial of a standard regimen of streptomycin, PAS and isoniazid and three alternative regimens of chemotherapy in Britain. A report from the British Medical Research Council.
    Tubercle; 1973 Jun; 54(2):99-129. PubMed ID: 4203162
    [No Abstract]   [Full Text] [Related]  

  • 11. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative controlled trial of rimactane in pulmonary tuberculosis.
    Dormer BA
    Int Z Klin Pharmakol Ther Toxikol; 1969 Apr; 2(2):188. PubMed ID: 4895449
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness and possibilities of application to ambulatory patients in our region of a pulmonary tuberculosis therapy by the intermittent administration (I.V.) of the triple association isoniazid-streptomycin-PAS (preliminary results after a year)].
    Burghard G; Petitjean R; Schranz J; Scherrer B
    Rev Tuberc Pneumol (Paris); 1970; 34(3):439-53. PubMed ID: 5515514
    [No Abstract]   [Full Text] [Related]  

  • 14. A controlled comparison of two fully supervised once-weekly regimens in the treatment of newly diagnosed pulmonary tuberculosis.
    Tubercle; 1973 Mar; 54(1):23-45. PubMed ID: 4204397
    [No Abstract]   [Full Text] [Related]  

  • 15. Practical results of standard first-line treatment in pulmonary tuberculosis : influence of primary resistance.
    Abderrahim K; Chaulet P; Oussedik N; Amrane R; Hassen CS; Mercer N
    Bull Int Union Tuberc; 1976; 51(1):359-66. PubMed ID: 1030307
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative studies of mycobacterial populations in sputum and saliva.
    Yeager H; Lacy J; Smith LR; LeMaistre CA
    Am Rev Respir Dis; 1967 Jun; 95(6):998-1004. PubMed ID: 4961042
    [No Abstract]   [Full Text] [Related]  

  • 17. [Proceedings: Results of a controlled trial of intermittent ambulatory therapy of infectious pulmonary tuberculosis with comparison of various maintenance regimens].
    Ganguin HG; Cramer G; Götz J; Holzhauer H; Niegsch G; Sieler H; Velten G; Völker L
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):107-15. PubMed ID: 4203235
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of two regimens of simplified two-stage chemotherapy in previously untreated pulmonary tuberculosis.
    Bethlem N; Gerhardt FO G; Magarăo S
    Tubercle; 1973 Sep; 54(3):180-4. PubMed ID: 4204111
    [No Abstract]   [Full Text] [Related]  

  • 19. Results and randomized original treatment in cases of pulmonary tuberculosis with isoniazid-streptomycin versus isoniazid-thiocarlide.
    Favez G; Gonin JD; Gubéran E; De Kalbermatten JP; Willa C; Vulliémoz P
    Chest; 1970 Mar; 57(3):234-8. PubMed ID: 5461222
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of isoniazid prophylaxis after exposure to isoniazid-resistant tuberculosis.
    Fairshter RD; Randazzo GP; Garlin J; Wilson AF
    Am Rev Respir Dis; 1975 Jul; 112(1):37-42. PubMed ID: 807140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.